🇺🇸 SULFAGUANIDINE in United States

726 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Discomfort — 75 reports (10.33%)
  2. Rash — 75 reports (10.33%)
  3. Arthropathy — 74 reports (10.19%)
  4. Lower Respiratory Tract Infection — 74 reports (10.19%)
  5. Pulmonary Pain — 74 reports (10.19%)
  6. Off Label Use — 72 reports (9.92%)
  7. Product Dose Omission Issue — 72 reports (9.92%)
  8. Drug Abuse — 70 reports (9.64%)
  9. Intentional Product Misuse — 70 reports (9.64%)
  10. Overdose — 70 reports (9.64%)

Source database →

SULFAGUANIDINE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is SULFAGUANIDINE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for SULFAGUANIDINE in United States?

Marketing authorisation holder not available in our data.